Lucro Operacional Alterar Data
Abbott USD 1.36B 775M 2026-09
Accuray USD 4.71M 6.86M 2024-12
AngioDynamics USD -2.51M 5.41M 2025-09
Artivion USD 4.79M 6.85M 2025-12
AtriCure USD 4.35M 5.31M 2026-09
Boston Scientific USD 1.01B 232M 2026-09
Edwards Lifesciences USD 542.7M 23.2M 2026-09
Inogen USD -7.79M 728K 2024-09
Mesa Laboratories USD 5.78M 2.27M 2024-12
Orthofix International USD 6.12M 1.91M 2025-12
Tandem Diabetes Care USD -2.37M 11.42M 2026-09
Trinity Biotech USD -1.79M 481K 2026-03